Funder
Bill & Melinda Gates Foundation
Reference16 articles.
1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022
2. The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: a semi-parametric, meta-regression approach;Antillón;PLoS Med,2023
3. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape;Mazur;Lancet Infect Dis,2022
4. WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015;Modjarrad;Vaccine,2016
5. Giersing BK, Karron RA, Vekemans J, Kaslow DC, Moorthy VS. Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016. In: Vaccine. Elsevier Ltd, 2019: 7355–7362.